John Overdeck’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$733K Buy
10,684
+237
+2% +$13.5K ﹤0.01% 3863
2026
Q1
$671K Sell
10,447
-14,527
-58% -$1.32M ﹤0.01% 3529
2025
Q4
$3.25M Sell
24,974
-105,459
-81% -$14.5M ﹤0.01% 2085
2025
Q3
$14.1M Buy
130,433
+7,684
+6% +$837K 0.02% 796
2025
Q2
$11.3M Buy
122,749
+94,391
+333% +$7.41M 0.02% 767
2025
Q1
$2.51M Sell
28,358
-123,715
-81% -$10.7M 0.01% 1595
2024
Q4
$11.7M Buy
152,073
+111,657
+276% +$7.8M 0.03% 682
2024
Q3
$1.72M Buy
40,416
+1,235
+3% +$41.7K ﹤0.01% 1767
2024
Q2
$1.02M Buy
39,181
+23,311
+147% +$442K ﹤0.01% 1969
2024
Q1
$145K Buy
15,870
+1,406
+10% +$8.44K ﹤0.01% 2784
2023
Q4
$39.8K Buy
+14,464
New +$33.6K ﹤0.01% 3011
2023
Q3
Sell
-12,551
Closed -$74.8K 3244
2023
Q2
$74.8K Sell
12,551
-13,323
-51% -$105K ﹤0.01% 2782
2023
Q1
$312K Buy
25,874
+21,735
+525% +$290K ﹤0.01% 2399
2022
Q4
$36K Buy
+4,139
New +$91.2K ﹤0.01% 2627
2022
Q3
Sell
-6,846
Closed -$285K 2858
2022
Q2
$285K Buy
+6,846
New +$464K ﹤0.01% 2044
2022
Q1
Sell
-20,490
Closed -$3.02M 4454
2021
Q4
$3.02M Buy
+20,490
New +$4.58M 0.01% 1571

Other funds holding WGS

John Overdeck's WGS Position: Q2 2026 in Review

John Overdeck increased its GeneDx Holdings (WGS) stake by 2.3% in Q2 2026, buying an estimated $13.5K and bringing the position to 10,684 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #3863.

John Overdeck first reported a position in WGS in Q4 2021 and has held it in 16 quarters since. The position peaked at $14.1M in Q3 2025. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • John Overdeck held 10,684 shares of GeneDx Holdings worth $733K as of Q2 2026.
  • John Overdeck bought 237 GeneDx Holdings shares in Q2 2026, an estimated $13.5K.
  • GeneDx Holdings made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3863 holding.
  • John Overdeck first reported a position in GeneDx Holdings in Q4 2021 and has held it in 16 quarters since.
  • John Overdeck's GeneDx Holdings position peaked at $14.1M in Q3 2025.
  • 222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.